TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Oncology
Elevated human chorionic gonadotrophin levels outside of pregnancy
Key Statistics
- 8% — Women >55y with pituitary hCG rise
- 1:60,000 — Families – Familial hCG syndrome
- 1:1000–1:10,000 — Phantom hCG prevalence
Don't-miss facts
-
hCG value alone never determines aetiology – always need ≥2 serial serum measurements plus history/imaging
-
Phantom hCG: serum >50 IU/mL with negative urine hCG; test both urine and serum, notify lab for alternative assay
-
Pituitary hCG confirmed by suppression with ≥2 weeks combined oestrogen–progesterone; levels track with rising FSH
-
Complete mole progression risk 13–15% (p57-negative); partial mole 0.5–1% (p57-positive)
-
Refer to trophoblast centre: persistent hCG post-ectopic exclusion, persistent hCG after 2× MTX doses for PUL, suspected mole/invasive mole/choriocarcinoma, PSN histology review, suspected PSTT/ETT/APSN
-
FIGO score ≤6 = low risk (IM methotrexate); ≥7 = high risk (EMA/CO); ≥13 = very poor prognosis
-
PSTT/ETT: low/undetectable hCG, chemo-resistant – treat surgically
-
Biotin >20 mg/day – avoid sampling within 8h (assay interference)
Benign vs malignant – quick differentiators
Benign: pituitary hCG, familial hCG, phantom hCG, exogenous hCG, factitious disorder, TOA/adenomyosis, drugs/biotin
Malignant: hydatidiform mole, invasive mole, choriocarcinoma, ETT/PSTT, APSN, ovarian GCTs, ectopic (non-GTD) hCG
Abbreviation Key
- hCG — human chorionic gonadotrophin
- GnRH — gonadotrophin-releasing hormone
- GTD — gestational trophoblastic disease
- TSH — thyroid-stimulating hormone
- GTN — gestational trophoblastic neoplasia
- POI — premature ovarian insufficiency
- ETT — epithelioid trophoblastic tumour
- TOA — tubo-ovarian abscess
- PSTT — placental site trophoblastic tumour
- MTX — methotrexate
- APSN — atypical placental site nodule
- MDT — multidisciplinary team
- PSN — placental site nodule
- EMA/CO — etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine
- GCT — germ cell tumour
- RMI — risk of malignancy index
- AFP — alpha-fetoprotein
- PET-CT — positron emission tomography–computed tomography
- LDH — lactate dehydrogenase
- DSM-5-TR — Diagnostic and Statistical Manual of Mental Disorders,
- FSH — follicle-stimulating hormone 5th ed., Text Revision
- LH — luteinising hormone
Source: Armata IE, Parker VL, et al. Elevated human chorionic gonadotrophin levels outside of pregnancy: a screening algorithm. The Obstetrician & Gynaecologist 2026;28:51–62. doi:10.1111/tog.70024
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).